News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoPharm (NEOL) Signs IL-13 Related CRADA with National Institute Of Neurological Disorders/ National Institutes of Health (NIH) for Research on the Therapeutic Agent for Untreatable Brain Diseases


10/15/2008 9:55:32 AM

LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (NASDAQ: NEOL), today announced that the Company has signed a Cooperative Research and Development Agreement (the “CRADA”) with the National Institute of Neurological Diseases and Stroke (NINDS), a part of the National Institutes of Health (NIH) for research on a therapeutic agent for untreatable brain diseases in humans.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES